Kaya Holdings, INC 8-K filings

Kaya Holdings, Inc. announced the appointment of seasoned attorney Richard D. Seay to its board of directors, effective November 25, 2025.

Kaya Holdings, Inc. announced a significant debt-to-equity conversion, resulting in a change of control, as it pivots towards a digital assets treasury strategy.

Kaya Holdings, Inc. has engaged Greentree Financial Group and Conduit Advisors to develop a new cryptocurrency operating subsidiary and implement a Digital Assets Treasury strategy.

Carrie Schwarz resigned from her position as a director of Kaya Holdings, Inc., effective April 24, 2025.

Kaya Holdings has announced the launch of its psilocybin treatment center, The Sacred Mushroom, in Portland, Oregon, as reported by television station KATU.

Kaya Holdings has amended its Certificate of Incorporation to increase the number of authorized common stock shares from 500 million to 1.5 billion.

Kaya Holdings, Inc. has announced the grand opening of its psilocybin treatment center, The Sacred Mushroom, in Portland, Oregon, with the CEO being the first to receive treatment.

Kaya Holdings has announced the opening of its psilocybin treatment center, The Sacred Mushroom, in Portland, Oregon, marking a significant step into the psychedelic medicine market.

Kaya Holdings has been awarded a license to operate its psilocybin treatment center, The Sacred Mushroom, in Oregon, marking a significant step in the company's expansion into the psychedelic therapy market.